Pregnancy Experience: Nonclinical Studies and Pregnancy Outcomes in the Daclizumab Clinical Study Program
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-6536
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Pregnancy Experience: Nonclinical Studies and Pregnancy Outcomes in the Daclizumab Clinical Study Program ; day:13 ; month:7 ; year:2016 ; pages:1-14
Neurology and Therapy ; (13.7.2016), 1-14
- Creator
-
Gold, Ralf
- Contributor
-
Stefoski, Dusan
Selmaj, Krzysztof
Havrdová, Eva
Hurst, Christopher
Holman, Joan
Tornesi, Belen
Akella, Surekha
McCroskery, Peter
SpringerLink (Online service)
- DOI
-
10.1007/s40120-016-0048-2
- URN
-
urn:nbn:de:1111-201610242220
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gold, Ralf
- Stefoski, Dusan
- Selmaj, Krzysztof
- Havrdová, Eva
- Hurst, Christopher
- Holman, Joan
- Tornesi, Belen
- Akella, Surekha
- McCroskery, Peter
- SpringerLink (Online service)
Other Objects (12)
Multiple Sklerose - zwischen Grundlagenforschung und klinischer Anwendung
Disease activity and neonatal outcomes after exposure to natalizumab throughout pregnancy
Krankheitsmodifizierende Therapie der sekundär progredienten Multiplen Sklerose
Management of Immune-Mediated Paraneoplastic Neurological Disorders
Efficacy and Safety of Multiple Sclerosis Drugs Approved Since 2018 and Future Developments
Multiple sclerosis disease activity and disability following cessation of Fingolimod for pregnancy
Multiple sclerosis disease activity and disability following discontinuation of natalizumab for pregnancy
Simultane Modulation des perzeptuellen Lernens und der kortikalen Exzitabilität des somatosensorischen Kortex durch taktile Koaktivierung
CMV meningitis associated with dimethyl fumarate therapy-induced lymphopenia in a multiple sclerosis patient
Effekte der immunmodulatorischen Substanz Laquinimod im Rattenmodell der Experimentellen Autoimmunen Neuritis
Connexin 43 and Aquaporin 4 modulations in astrocyte, microglia, and glioma cells under therapeutic interference in vitro
CMV meningitis associated with dimethyl fumarate therapy-induced lymphopenia in a multiple sclerosis patient
Multiple Sklerose - zwischen Grundlagenforschung und klinischer Anwendung
Disease activity and neonatal outcomes after exposure to natalizumab throughout pregnancy
Krankheitsmodifizierende Therapie der sekundär progredienten Multiplen Sklerose
Management of Immune-Mediated Paraneoplastic Neurological Disorders
Efficacy and Safety of Multiple Sclerosis Drugs Approved Since 2018 and Future Developments
Multiple sclerosis disease activity and disability following cessation of Fingolimod for pregnancy
Multiple sclerosis disease activity and disability following discontinuation of natalizumab for pregnancy
Simultane Modulation des perzeptuellen Lernens und der kortikalen Exzitabilität des somatosensorischen Kortex durch taktile Koaktivierung
CMV meningitis associated with dimethyl fumarate therapy-induced lymphopenia in a multiple sclerosis patient
Effekte der immunmodulatorischen Substanz Laquinimod im Rattenmodell der Experimentellen Autoimmunen Neuritis
Connexin 43 and Aquaporin 4 modulations in astrocyte, microglia, and glioma cells under therapeutic interference in vitro
CMV meningitis associated with dimethyl fumarate therapy-induced lymphopenia in a multiple sclerosis patient
Multiple Sklerose - zwischen Grundlagenforschung und klinischer Anwendung
Disease activity and neonatal outcomes after exposure to natalizumab throughout pregnancy
Krankheitsmodifizierende Therapie der sekundär progredienten Multiplen Sklerose
Management of Immune-Mediated Paraneoplastic Neurological Disorders
Efficacy and Safety of Multiple Sclerosis Drugs Approved Since 2018 and Future Developments
Multiple sclerosis disease activity and disability following cessation of Fingolimod for pregnancy
Multiple sclerosis disease activity and disability following discontinuation of natalizumab for pregnancy
Simultane Modulation des perzeptuellen Lernens und der kortikalen Exzitabilität des somatosensorischen Kortex durch taktile Koaktivierung
CMV meningitis associated with dimethyl fumarate therapy-induced lymphopenia in a multiple sclerosis patient
Effekte der immunmodulatorischen Substanz Laquinimod im Rattenmodell der Experimentellen Autoimmunen Neuritis
Connexin 43 and Aquaporin 4 modulations in astrocyte, microglia, and glioma cells under therapeutic interference in vitro